DESCRIPTION (provided by applicant): This is Phase I of an SBIR grant application. The overall goal of this project is to enable the pharmaceutical industry to conduct high-throughput screening (HTS) studies with Fa2N-4 cells, a new cell line created by immortalizing human hepatocytes with SV-40…
More